Pfizer's atopic dermatitis treatment meets goals in late-stage study

Pfizer Inc's new atopic dermatitis treatment met the main goals in a late-stage study that tested the drug in patients aged 12 and older with moderate to severe forms of the disease, the drugmaker said on Wednesday.

from Reuters: Health https://reut.rs/2WSHICU
via IFTTT

• Tweet
• Share
• Share
• Share
• Share